SEC Form 4 · accession 0000899243-18-001902
Cardiff Oncology, Inc. · CRDF
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William J Welch
Officer — Chief Executive Officer · Director
Period of report
Jan 23, 2018
Accepted (ET)
Jan 25, 2018 · 5:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001213037
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options | $0.30 | Jan 23, 2018 | A | 662,500 | A | Jan 23, 2018 | Jan 23, 2028 | Common Stock | 662,500 | 1,412,500 | D |